Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: Role of cardiovascular sympathetic tone

Cardiovascular Research

Volumn 43, Issue 2, 1999, Pages 437-444

  Melo, Luis G ^a   Veress, Anthony T ^a   Ackermann, Uwe ^a   Steinhelper, Mark E ^b   Pang, Stephen C ^c   Tse, Yat ^c   Sonnenberg, Harald ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Autonomic nervous system; Blood pressure; Hypertension; Mice; Natriuretic peptide

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; GANGLION BLOCK; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SYMPATHETIC TONE; TRANSGENIC MOUSE; VASCULAR RESISTANCE;

ANALYSIS OF VARIANCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; EPINEPHRINE; GANGLIONIC BLOCKERS; HEART RATE; HEXAMETHONIUM; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; NOREPINEPHRINE; PROTEIN BINDING; RECEPTORS, ADRENERGIC; SYMPATHOMIMETICS;

EID: 0033178373     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00104-2     Document Type: Article

References (48)

1. Ackermann U., Irizawa T.G., Milojevic S., Sonnenberg H. Cardiovascular effects of atrial extracts in anesthetized rats. Can. J. Physiol. Pharmacol. 62:1984;819-826.
2. Kleinert H.D., Volpe M., Odell G., et al. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. Hypertension. 8:1986;312-316.
3. Breuhaus B.A., Saneii H.H., Brandt M.A., Chimoskey J.E. Atriopeptin II lowers cardiac output in conscious sheep. Am. J. Physiol. 249:1985;R776-R780.
4. Garcia R., Thibault G., Gutkowska J., et al. Chronic infusion of low doses of atrial natriuretic factor (ANF Arg 101-Tyr 126) reduces blood pressure in conscious SHR without apparent changes in sodium excretion. Proc. Soc. Exp. Biol. Med. 179:1985;396-401.
5. Harrison-Bernard L.M., Vari R.C., Holleman W.H., Trippodo N.C., Barbee R.W. Chronic vs. acute hemodynamic effects of atrial natriuretic factor in conscious rats. Am. J. Physiol. 260:1991;R247-R254.
6. Steinhelper M.E., Cochrane K.L., Field L.J. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension. 16:1990;301-307.
7. John S.W., Krege M.J.H., Oliver P.M., et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 267:1995;679-681.
8. Lopez M.J., Wong S.K.-F., Kishimoto I., et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 378:1995;65-68.
9. Field L.J., Veress A.T., Steinhelpher M.E., Cochrane K., Sonnenberg H. Kidney function in ANF-transgenic mice: effect of blood volume expansion. Am. J. Physiol. 260:1991;R1-R5.
10. John S.W.M., Veress A.T., Honrath U., et al. Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am. J. Physiol. 271:1996;R109-R114.
11. Veress A.T., Chong C.K., Field L.J., Sonnenberg H. Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets. Am. J. Physiol. 269:1995;R186-R192.
12. Barbee R.W., Perry B.D., Re R.N., Murgo J.P., Field L.J. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ. Res. 74:1995;747-751.
13. Melo L.G., Veress A.T., Ackermann U., et al. Chronic hypertension in ANP knockout mice: Contribution of peripheral resistance. Reg Pept. 79:1999;109-115.
14. Faison E.P., Siegel P.K.S., Morgan G., Winquist R.J. Regional vasorelaxant selectivity of atrial natriuretic factor in isolated rabbit vessels. Life Sci. 37:1985;1073-1079.
15. Winquist R.J., Faison E.P., Waldman S.A., et al. Atrial natriuretic peptide elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. USA. 81:1984;7661-7664.
16. Hintze T.H., Currie M.G., Needleman P. Atriopeptins: renal-specific vasodilators in conscious dogs. Am J. Physiol. 248:1985;H587-H591.
17. De Lean H., Bonhomme M.C., Thibault G., Garcia R. Localization of atrial natriuretic factor receptors in the mesenteric arterial bed: comparison with angiotensin II and endothelin receptors. Circ. Res. 77:1995;64-72.
18. Anand-Srivastava M.B., Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45:1993;455-497.
19. Barbee R.W., Harrison-Bernard L.M., Carmines P.K. Microvascular effects of atrial natriuretic peptide in rat cremaster. Peptides. 13:1992;1181-1185.
20. Klabunde R.E., Helgren M.C., Novosad E.I., Opgenorth T.G. Atrial natriuretic peptide (ANP) does not inhibit the basal vascular tone present in the in situ blood-perfused dog gracilis muscle. Life Sci. 47:1990;2027-2033.
21. Osol G., Halpern W., Tesfamariam B., Nakayama K., Weinberg D. Synthetic atrial natriuretic factor does not dilate resistance-sized arteries. Hypertension. 8:1986;606-610.
22. Melo L.G., Veress A.T., Ackermann U., Sonnenberg H. Chronic regulation of arterial blood pressure by ANP: Role of endogenous vasoactive endothelial factors. Am. J. Physiol. 275:1998;H1826-H1833.
23. Schultz H.D., Steele M.K., Gardner D.G. Central administration of atrial peptide decreases sympathetic outflow in rats. Am. J. Physiol. 258:1990;R1250-R1256.
24. Levin E.R., Weber M.A., Mills S. Atrial natriuretic factor-induced vasodepression occurs through central nervous system. Am. J. Physiol. 255:1988;H616-H622.
25. Debinski W., Kuchel O., Buu N.T., Cantin M., Genest J. Atrial natriuretic factor partially inhibits the stimulated cathecholamine synthesis in superior cervical ganglia of the rat. Neurosci Lett. 77:1987;92-96.
26. Nakamaru M., Inagami T. Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries. Eur. J. Pharmacol. 123:1986;459-461.
27. Bergey J.L., Much D.R., Kratunis V., Asaad M. Effects of human ANF-(99-126) on sympathetic nerve function and plasma ganglion-blocked dogs. Eur. J. Pharmacol. 159:1989;103-112.
28. Sasaki A., Kida O., Kangawa K., Matsuo H., Tanaka K. Involvement of cardiosuppressive effects of α-human atrial natriuretic polypeptide (α-hANP) in anesthetized rats. Eur. J. Pharmacol. 120:1986;345-349.
29. Pang S.C., Hoang M.C., Tremblay J., et al. Effect of natural and synthetic atrial natriuretic factor on arterial blood pressure, natriuresis and cyclic GMP excretion in spontaneously hypertensive rats. Clin. Sci. 69:1985;721-726.
30. Sweet W.D., Freeman R.H., Davis J.O., Vari R.C. Ganglionic blockade in conscious dogs with chronic caval constriction. Am. J. Physiol. 249:1985;H1038-H1044.
31. Micallizzi E.R., Pals D.T. Evaluation of plasma norepinephrine as an index of sympathetic neuron function in conscious unrestrained rat. Life Sci. 24:1979;2071-2076.
32. Peuler J.D., Johnson G.A. Simultaneous single isotope radioenzymatic assay of norepinephrine, epinephrine and dopamine. Life Sci. 21:1977;625-636.
33. Kuchel O., Debinski W., Racz K., et al. An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor. Life Sci. 40:1987;1545-1551.
34. Ermirio R., Ruggeri P., Cogo C.E., Molinari C., Calaresu F.R. Neuronal and cardiovascular responses to ANF microinjected into the solitary nucleus. Am. J. Physiol. 256:1989;R577-R582.
35. McKitrick D.J., Calaresu F.R. Cardiovascular responses to microinjection of ANF into dorsal medulla of rats. Am. J. Physiol. 255:1988;R182-R187.
36. Floras J.S. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans. Am. J. Physiol. 269:1995;R406-R412.
37. Holtz J., Sommer O., Bassenge B. Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs. Hypertension. 9:1987;350-354.
38. 2 adrenoceptors. Circ. Res. 63:1988;415-428.
39. Haass M., Kopin I.J., Goldstein D.S., Zukowska-Grojec Z. Differential inhibition of alpha adrenoceptor-mediated pressor responses by rat atrial natriuretic peptide in the pithed rat. J. Pharmacol. Exp. Ther. 235:1985;122-127.
40. Ackermann U., Khanna J., Irizawa T.G. Atrial natriuretic factor alters autonomic interactions in the control of heart rate in conscious rats. Can. J. Physiol. Pharmacol. 66:1988;930-936.
41. Atchison D.J., Ackermann U. The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J. Auton. Nervous Syst. 42:1993;81-88.
42. Fernandez B.E., Leder E.M., Fernandez G., Bianciotti L.G., Vatta M.S. Atrial natriuretic factor modifies the biosynthesis and turnover of norepinephrine in the rat adrenal medulla. Biochem. Biophys. Res. Commun. 238:1997;343-346.
43. Debinski W., Gutkowska J., Kuchel O., et al. ANF-like peptide(s) in the peripheral autonomic nervous system. Biochem. Biophys. Res. Commun. 134:1986;279-284.
44. Debinski W., Kuchel O., Buu N.T., Tremblay J., Hamet P. Atrial natriuretic factor constitutes an intrinsic functional unit within superior cervical ganglia of the rat. Neuroscience. 36:1990;21-26.
45. Mulvany M.J. Resistance vessel structure and the pathogenesis of hypertension. J. Hypertension. 11:(Suppl 5):1993;S7-S12.
46. Baumbach G.L., Ghoneim S. Vascular remodeling in hypertension. Scanning Microscopy. 7:1993;137-143.
47. Bevan R.D. Trophic effect of peripheral adrenergic nerves on vascular structure. Hypertension. 6:(Suppl. III):1984;III19-III28.
48. Folkow B., Hallback M., Lundgren Y., Weiss L. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol. Scand. 80:1970;93-106.